Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Characterization of multiple soluble immune checkpoints in individuals with different Mycobacterium tuberculosis infection status and dynamic changes during anti-tuberculosis treatment

Fig. 1

Profile of circulating sICs levels in individuals with distinct M. tb infection status. Dot plots of the circulating levels of co-inhibitory sICs, including sPD-1, sPD-L1, sPD-L2, sCTLA-4, sTIM-3, sLAG-3, sBTLA, sGITR, sIDO, and co-stimulatory sICs, including sCD28, sCD80, sCD27, s4-1BB, in PTB and TBP patients, LTBI and HC individuals at enrollment. sICs soluble immune checkpoints, PTB pulmonary tuberculosis, TBP tuberculous pleurisy, LTBI latent tuberculosis infection, HC healthy controls

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us